Technology | May 15, 2015

McKesson Offers iPad App to Review Cancer Protocols, Guidelines

Application highlights evidence-based treatment options at the point of care

McKesson Specialty Health, Guideline Explorer, cancer, iPad, Clear Value Plus

May 15, 2015 — McKesson Specialty Health announced the availability of Clear Value Plus – Guideline Explorer to iPad users. The Guideline Explorer app is a mobile reference tool that gives users access to evidence-based cancer protocols based on patient attributes.

Available for download on the Apple App Store at no cost, the Guideline Explorer app provides users with an easy-to-use interface for exploring patient-specific treatment options based on the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines) and Value Pathways powered by NCCN. Current Clear Value Plus users can access the complete range of evidence-based treatment options and see all treatment choices that are highlighted as part of the Value Pathways powered by NCCN. New iPad users can navigate NCCN Content and explore chemotherapy regimens based on specific patient characteristics and quickly view up-to-date chemotherapy options, as well as known side effect profiles.

The new iPad tool is an extension of McKesson Specialty Health’s Clear Value Plus, a quality support tool for oncologists that highlights evidence-based treatment options at the point of care. The software brings to life Value Pathways powered by NCCN and NCCN Guidelines within the clinical workflow—offering evidence-based protocols at the point of care with the patient. In addition, Clear Value Plus is compatible with multiple provider systems and provides integrated financial information, real-time reporting and benchmarking to demonstrate the value of delivering evidence-based care.

For more information: www.mckessonspecialtyhealth.com

Related Content

HealthMyne QIDS Platform Adds Cancer Screening Module
Technology | Clinical Decision Support | August 21, 2018
HealthMyne announced the release of Quantitative Imaging Decision Support (QIDS) 5 featuring a new, automated Cancer...
Doctor-Patient Discussions Neglect Potential Harms of Lung Cancer Screening
News | Lung Cancer | August 15, 2018
August 15, 2018 — Although national guidelines advise doctors to discuss the benefits and harms of...
Videos | Radiation Therapy | August 13, 2018
ITN Editor Dave Fornell takes a tour of some of the innovative new technologies on the expo floor at the 2018 America
ACR LI-RADS Steering Committee Releases New Version of CT/MRI LI-RADS
News | Clinical Decision Support | August 13, 2018
August 13, 2018 — The American College of Radiology Liver Imaging Reporting and Data System (LI-RADS) steering commit
Videos | Radiation Therapy | August 13, 2018
A discussion with Mahadevappa Mahesh, MS, Ph.D., FAAPM, FACR, FACMP, FSCCT, professor of radiology and cardiology and
Videos | Proton Therapy | August 10, 2018
A discussion with Matthew Freeman, Ph.D., scientist at Los Alamos National Laboratory, New Mexico.
Exact Imaging Becomes UroGPO Imaging Partner
News | Ultrasound Imaging | August 10, 2018
Exact Imaging announced that it has become a UroGPO Imaging Partner, joining the North American urology-specific group...
Videos | Radiomics | August 09, 2018
A discussion with Martin Vallieres, Ph.D., post-doctoral fellow at McGill University, Montreal, Canada.
Aidoc Receives FDA Clearance for AI Detection of Acute Intracranial Hemorrhage
Technology | Clinical Decision Support | August 08, 2018
Aidoc announced that it was granted U.S. Food and Drug Administration (FDA) clearance for the first product of its...
Metro Health-University of Michigan Health Partners With Eon to Improve Lung Cancer Care
News | Oncology Diagnostics | August 07, 2018
Metro Health-University of Michigan Health announced it is partnering with healthcare data company Eon to improve the...
Overlay Init